Gene · 6646
Papers1,513
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 1,513
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| OTTM: an automated classification tool for translational drug discovery from omics data. | Brief Bioinform | 2023 | 37594310 | PubTator, text mining | PubMed |
| Comparative Biophysical Study of Meibomian Lipids of Wild Type and Soat1-Null Mice: Implications to Meibomian Gland Dysfunction and Dry Eye Disease. | Invest Ophthalmol Vis Sci | 2023 | 37585190 | PubTator, text mining | PubMed |
| Proteomics of adjacent-to-tumor samples uncovers clinically relevant biological events in hepatocellular carcinoma. | Natl Sci Rev | 2023 | 37575948 | PubTator, text mining | PubMed |
| Methylome evolution suggests lineage-dependent selection in the gastric pathogen Helicobacter pylori. | Commun Biol | 2023 | 37573385 | PubTator, text mining | PubMed |
| Benzophenones-natural metabolites with great Hopes in drug discovery: structures, occurrence, bioactivities, and biosynthesis. | RSC Adv | 2023 | 37546221 | PubTator, text mining | PubMed |
| Lysophosphatidylglucoside/GPR55 signaling promotes foam cell formation in human M2c macrophages. | Sci Rep | 2023 | 37544935 | PubTator, text mining | PubMed |
| Lysosomal acidification dysfunction in microglia: an emerging pathogenic mechanism of neuroinflammation and neurodegeneration. | J Neuroinflammation | 2023 | 37543564 | PubTator, text mining | PubMed |
| Aberrations in ion channels interacting with lipid metabolism and epithelial-mesenchymal transition in esophageal squamous cell carcinoma. | Front Mol Biosci | 2023 | 37529379 | PubTator, text mining | PubMed |
| The Hypocholesterolemic Potential of the Edible Algae Fucus vesiculosus: Proteomic and Quantitative PCR Analysis. | Foods | 2023 | 37509850 | PubTator, text mining | PubMed |
| The effects of hesperidin supplementation on cardiovascular risk factors in adults: a systematic review and dose-response meta-analysis. | Front Nutr | 2023 | 37502716 | PubTator, text mining | PubMed |
| Comprehensive analysis of the clinical and biological significances of cholesterol metabolism in lower-grade gliomas. | BMC Cancer | 2023 | 37488496 | PubTator, text mining | PubMed |
Stealth Liposomes Encapsulating a Potent ACAT1/SOAT1 Inhibitor F12511: Pharmacokinetic, Biodistribution, and Toxicity Studies in Wild-Type Mice and Efficacy Studies in Triple Transgenic Alzheimer's Disease Mice. | Int J Mol Sci | 2023 | 37446191 | PubTator, text mining | PubMed |
| SREBP-1 upregulates lipophagy to maintain cholesterol homeostasis in brain tumor cells. | Cell Rep | 2023 | 37436895 | PubTator, text mining | PubMed |
| Integrated High-Throughput Bioinformatics (Microarray, RNA-Seq, and RNA Interaction) and qRT-PCR Investigation of BMPR1B Axis as a Potential Diagnostic Biomarker of Isfahan Breast Cancer. | Adv Biomed Res | 2023 | 37434942 | PubTator, text mining | PubMed |
| Aberrant LYZ expression in tumor cells serves as the potential biomarker and target for HCC and promotes tumor progression via csGRP78. | Proc Natl Acad Sci U S A | 2023 | 37428911 | PubTator, text mining | PubMed |
| NPC1 plays a role in the trafficking of specific cargo to melanosomes. | J Biol Chem | 2023 | 37423302 | PubTator, text mining | PubMed |
| The regulatory role of lipophagy in central nervous system diseases. | Cell Death Discov | 2023 | 37414782 | PubTator, text mining | PubMed |
| Targeting sterol-O-acyltransferase 1 to disrupt cholesterol metabolism for cancer therapy. | Front Oncol | 2023 | 37409263 | PubTator, text mining | PubMed |
| Aberrant cholesterol metabolism in colorectal cancer represents a targetable vulnerability. | Genes Dis | 2023 | 37397513 | PubTator, text mining | PubMed |
| Accelerated export of Dicer1 from lipid-challenged hepatocytes buffers cellular miRNA-122 levels and prevents cell death. | J Biol Chem | 2023 | 37394005 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6646/papers?page=10